Cephalon's Frank Baldino - CEO Pay

Frank Baldino - Cephalon

Total Compensation: $14.5M

Details: In 2007, with an overall salary of $13.5 million, Baldino managed to pull down $2 million more than the previous year. The CEO--who's paid much more than those in his peer group--didn't manage such a hefty salary jump in 2008. With his total compensation rounding out to $14.5 million, Baldino's 2008 raise came in at just under $1 million last year. His salary included $63,750 for personal use of the company car, insurance, financial planning and medical reimbursements.

Cephalon News:
Cephalon hikes prices to fight generic
Cephalon finalizes $425M off-label settlement
FDA approves Cephalon's Treanda
FDA panel rejects broader Fentora use
FTC sues Cephalon for blocking generics
Cephalon, NitroMed make cuts jobs

Cephalon's Frank Baldino - CEO Pay
Read more on

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.